Anaplastic Lymphoma Kinase (ALK) was first discovered in 1994 as part of the nucleophosmin (NPM)-ALK fusion resulting from the highly recurrent (2;5)(p23;q35) translocation in anaplastic large cell lymphomas (ALCL) [1,2]. This evidence concerns the gene ALK and anaplastic large cell lymphoma.